Skip to Main Content

Paper Details

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.
Int J Cancer
69
2018
Author NameAffiliation
Antonio CubilloHM Universitario Sanchinarro, and Departamento de Ciencias Medicas Clinicas, Universidad CEU San Pablo
  • 1 - 1

Datasets

Release 1.2